AlerisLife Inc. (NASDAQ: ALR) stock jumped 43.70% on Friday to $1.71 against a previous-day closing price of $1.19. With 2.53 million shares changed hands, the volume of the stock remained heavier than its average volume of 69610.0 shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $2.1600 whereas the lowest price it dropped to was $1.1612. The 52-week range on ALR shows that it touched its highest point at $5.25 and its lowest point at $1.06 during that stretch. It currently has a 1-year price target of $1.50. Beta for the stock currently stands at 0.91.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ALR was up-trending over the past week, with a rise of 48.70%, but this was up by 50.00% over a month. Three-month performance surged to 11.04% while six-month performance fell -40.83%. The stock lost -63.07% in the past year, while it has lost -42.03% so far this year. A look at the trailing 12-month EPS for ALR yields -1.36 with Next year EPS estimates of -0.29. For the next quarter, that number is -0.17. This implies an EPS growth rate of -292.80% for this year and 63.70% for next year. EPS is expected to grow by 14.25% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 26.80%.
Float and Shares Shorts:
At present, 31.79 million ALR shares are outstanding with a float of 19.02 million shares on hand for trading. On Jul 14, 2022, short shares totaled 0.15 million, which was 0.45% higher than short shares on Jun 14, 2022. In addition to Mr. Adam David Portnoy as the firm’s Chairman & MD, Mr. Jeffrey C. Leer serves as its Exec. VP, CFO, Pres & CEO.
Through their ownership of 30.64% of ALR’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 41.65% of ALR, in contrast to 5.00% held by mutual funds. Shares owned by individuals account for 31.57%. As the largest shareholder in ALR with 6.06% of the stake, RMR Advisors LLC holds 1,972,783 shares worth 1,972,783. A second-largest stockholder of ALR, V3 Capital Management LP, holds 1,544,580 shares, controlling over 4.75% of the firm’s shares. Newtyn Management LLC is the third largest shareholder in ALR, holding 1,500,000 shares or 4.61% stake. With a 1.65% stake in ALR, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 537,058 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 0.96% of ALR stock, is the second-largest Mutual Fund holder. It holds 312,843 shares valued at 0.38 million. DFA US Targeted Value Portfolio holds 0.34% of the stake in ALR, owning 111,915 shares worth 0.13 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ALR since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With ALR analysts setting a high price target of $1.50 and a low target of $1.50, the average target price over the next 12 months is $1.50. Based on these targets, ALR could drop -12.28% to reach the target high and fall by -12.28% to reach the target low. Reaching the average price target will result in a decline of -12.28% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. ALR will report FY 2022 earnings on 03/07/2023. Analysts have provided yearly estimates in a range of -$0.80 being high and -$0.80 being low. For ALR, this leads to a yearly average estimate of -$0.80. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. AlerisLife Inc. surprised analysts by -$0.04 when it reported -$0.25 EPS against a consensus estimate of -$0.21. The surprise factor in the prior quarter was -$0.18. Based on analyst estimates, the high estimate for the next quarter is -$0.17 and the low estimate is -$0.17. The average estimate for the next quarter is thus -$0.17.
Summary of Insider Activity:
Insiders traded ALR stock several times over the past three months with 7 Buys and 0 Sells. In these transactions, 87,500 shares were bought while 0 shares were sold. The number of buy transactions has increased to 12 while that of sell transactions has risen to 4 over the past year. The total number of shares bought during that period was 577,500 while 32,627 shares were sold.